Skip to main content
. 2022 Oct 28;23(21):13138. doi: 10.3390/ijms232113138

Figure 2.

Figure 2

An EIS specificity response towards 0.6 pg/mL of MERS-CoV RBD S glycoprotein, influenza HA peptide, HSA, and the target SARS-CoV-2 S glycoprotein. A buffer without the aptamer was used as a negative control. Data are presented as the means of ± standard deviation and standard error of the mean (n = 3).